Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Buckingham

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Laboratory and Clinical Medicine|May 1, 1983
Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycanR B Buckingham, R K Prince, G P Rodnan
Journal of Inherited Metabolic Disease|July 1, 1997
Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduriaK M Gibson, G F Hoffmann, L Sweetman, et al.
Cancer|March 1, 1977
Metaplastic squamous cell carcinoma of bronchus simulating giant cell tumor of boneR Oyasu, H A Battifora, W B Buckingham, et al.
Pain|May 1, 1984
A psychophysical analysis of acupuncture analgesiaD D Price, A Rafii, L R Watkins, et al.
Arthritis and Rheumatism|October 1, 1988
Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissuesT L Whiteside, M Ferrarini, P Hebda, et al.
Diabetes/Metabolism Research and Reviews|April 14, 2011
Metabolic tests to determine risk for type 1 diabetes in clinical trialsCarla J Greenbaum, B Buckingham, H P Chase, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1978
Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma)R B Buckingham, R K Prince, G P Rodnan, et al.
Annals of the Rheumatic Diseases|June 1, 1976
Measurement of circumference of the knee with ordinary tape measureJ J Nicholas, F H Taylor, R B Buckingham, et al.
Diabetes Research (Edinburgh, Scotland)|June 1, 1986
Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitusS Gupta, M A Charles, N Waldeck, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
A naturally occurring 6-9-kilodalton interleukin-1 (IL-1) inhibitor prevents IL-1-mediated islet cytotoxicity but not IL-1-mediated suppression of insulin secretionD J Kawahara, M Everts, B Buckingham, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Laboratory and Clinical Medicine|May 1, 1983
Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycanR B Buckingham, R K Prince, G P Rodnan
Journal of Inherited Metabolic Disease|July 1, 1997
Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduriaK M Gibson, G F Hoffmann, L Sweetman, et al.
Cancer|March 1, 1977
Metaplastic squamous cell carcinoma of bronchus simulating giant cell tumor of boneR Oyasu, H A Battifora, W B Buckingham, et al.
Pain|May 1, 1984
A psychophysical analysis of acupuncture analgesiaD D Price, A Rafii, L R Watkins, et al.
Arthritis and Rheumatism|October 1, 1988
Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissuesT L Whiteside, M Ferrarini, P Hebda, et al.
Diabetes/Metabolism Research and Reviews|April 14, 2011
Metabolic tests to determine risk for type 1 diabetes in clinical trialsCarla J Greenbaum, B Buckingham, H P Chase, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1978
Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma)R B Buckingham, R K Prince, G P Rodnan, et al.
Annals of the Rheumatic Diseases|June 1, 1976
Measurement of circumference of the knee with ordinary tape measureJ J Nicholas, F H Taylor, R B Buckingham, et al.
Diabetes Research (Edinburgh, Scotland)|June 1, 1986
Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitusS Gupta, M A Charles, N Waldeck, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
A naturally occurring 6-9-kilodalton interleukin-1 (IL-1) inhibitor prevents IL-1-mediated islet cytotoxicity but not IL-1-mediated suppression of insulin secretionD J Kawahara, M Everts, B Buckingham, et al.
Pageof 10